CVD

Global PET Scanners Market Report 2023: Sector is Expected to Reach $1.94 Billion by 2030 at a CAGR of 5.4% - ResearchAndMarkets.com

Retrieved on: 
Monday, May 29, 2023
Medical Devices, Health, Radiation, Prevalence, Noise, TUM, Institute of technology, Cancer, PET, Virtual pet, CVD, Radiopharmaceutical, PET-CT, Bayesian operational modal analysis, Teaching hospital, MRI, Siemens Healthineers, Magnetic resonance imaging, Acquisition, Patient, Chapter Five, Algorithm, PET/CT, Artificial intelligence, Growth, Diagnosis, Digital, AI, Cardiology, Radiation exposure, Prostate cancer, Medical imaging

Digital PET scanners use advanced detectors that can precisely measure the amount of radiation emitted by the tracer.

Key Points: 
  • Digital PET scanners use advanced detectors that can precisely measure the amount of radiation emitted by the tracer.
  • However, as AI technology continues to advance, it is likely to drive the growth of the PET scanners market in the future.
  • The diagnostic imaging centers segment is expected to witness the fastest CAGR of 5.7% over the forecast period.
  • Chapter 5 Pet Scanners Market: Modality Analysis
    Chapter 6 Pet Scanners Market: Application Analysis
    Chapter 7 Pet Scanners Market: End-Use Analysis
    Chapter 8 Pet Scanners Market: Regional Analysis

New Viewer and Glasses for Color Blind Visitors Now Available at Ventura Botanical Gardens

Retrieved on: 
Tuesday, May 30, 2023
Ventura Botanical Gardens, Color blindness, University, Woman, Merewether, New South Wales, Drama, Aloe, CVD, Paratriathlon, Plant, School, Student, Work, Nature, Museum, Library, Amusement park, Drinking establishment, Television, EnChroma

VENTURA, Calif., May 30, 2023 /PRNewswire-PRWeb/ -- The Ventura Botanical Gardens and EnChroma® – creators of glasses for color blindness – announced this week the installation of a special viewer for colorblind visitors. The Gardens is first botanical gardens in California to have a viewer for color blind visitors onsite, as well as special EnChroma glasses for color blindness for guests to borrow.

Key Points: 
  • The Ventura Botanical Gardens first in California to support "Color Accessibility" with the installation of a special viewer and EnChroma glasses for colorblind visitors to use.
  • VENTURA, Calif., May 30, 2023 /PRNewswire-PRWeb/ -- The Ventura Botanical Gardens and EnChroma ® – creators of glasses for color blindness – announced this week the installation of a special viewer for colorblind visitors.
  • The Gardens is first botanical gardens in California to have a viewer for color blind visitors onsite, as well as special EnChroma glasses for color blindness for guests to borrow.
  • The installation of the viewer, and availability of the glasses, are part of the Ventura Botanical Gardens support for accessibility and inclusivity for visitors.

Flat Panel Display (FPD) Equipment Market Report 2023: Growing Demand for Consumer Electronics and Automotive Displays Underpins Sector

Retrieved on: 
Friday, May 26, 2023
PVD, E-procurement, Electronics, United States Census Bureau, COVID-19, FPD, CVD, Tablet, OLED, Lam Research, Flat, Growth, ADAS, Silicon, Glass, Flat-panel display, Television, Geography, Beauty salon, Printed circuit board

The flat panel display (FPD) equipment market is projected to grow at a CAGR of 3.35%, reaching US$8.763 billion in 2028 from US$6.956 billion in 2021.

Key Points: 
  • The flat panel display (FPD) equipment market is projected to grow at a CAGR of 3.35%, reaching US$8.763 billion in 2028 from US$6.956 billion in 2021.
  • The flat panel display (FPD) equipment market is driven by growing demand for consumer electronics and rising demand for large-screen and automotive displays.
  • Growing demand for consumer electronics- The increasing demand for smartphones, laptops, tablets, and other consumer electronic devices is driving the growth of the FPD equipment market.
  • The flat panel display (FPD) equipment market in North America is mainly driven by the high demand for consumer electronics, such as smartphones, laptops, and tablets.

Bempedoic acid significantly reduces the risk of major adverse cardiovascular events, and increased combination therapies can help more patients achieve LDL-C goals — late breaking EAS data

Retrieved on: 
Tuesday, May 23, 2023
Pharmaceutical, Health, Clinical Trials, Cardiology, EAS, CV, Myocardial infarction, Lipid, Cardiovascular disease, ATP, Splenic infarction, RRR, CVD, Agent handling, Incidence, Public health, Patient, Standard of care, Physician, Risk, Guideline, Daiichi Sankyo, Disease, Mortality, Principal, ESC, ACL, Therapy, Death, Imperial College London, Pharmaceutical industry, Dietary supplement

Both studies were presented in a late-breaker session at the 91st European Atherosclerosis Society congress.

Key Points: 
  • Both studies were presented in a late-breaker session at the 91st European Atherosclerosis Society congress.
  • Nearly 80% of patients who are at high- or very high-risk of CV events in Europe do not attain the guideline-recommended LDL-C goals, putting them at high risk of suffering an acute and often life-threatening cardiovascular event.
  • The CLEAR Outcomes trial answers those remaining questions and shows that bempedoic acid reduces the risk of major cardiovascular events in patients at high- and very high-risk.
  • We now know that, as an additional treatment option, bempedoic acid can not only help patients reach their guideline LDL-C recommendations but also lower their CV risk.

Holter ECG Markets by Product (Wired Holter ECG, Wireless Holter ECG, Software), Lead Type (Patch Type 1-Lead, 3-Lead, 6-Lead, 12-Lead) - Global Forecast to 2027

Retrieved on: 
Wednesday, May 24, 2023
GE HealthCare, Holter, OSI Systems, Prevalence, Cardiovascular disease, Ageing, GE, CVD, USD, Growth, Diagnosis, Cardiology, Software, Medical device

The global Holter ECG market is projected to reach USD 558 million by 2027 from USD 416 million in 2022, at a CAGR of 6.1% during the forecast period.

Key Points: 
  • The global Holter ECG market is projected to reach USD 558 million by 2027 from USD 416 million in 2022, at a CAGR of 6.1% during the forecast period.
  • Based on product, the Holter ECG market is segmented into wired Holter ECG monitors, wireless Holter ECG monitors, and software.
  • The wired Holter ECG monitors segment is expected to witness a high market share during the forecast period.
  • Based on lead type, the Holter ECG market is segmented into patch type 1-lead, 3-lead, 6-lead, 12-lead, and other lead types (such as 4-, 5-, and 7-lead Holter ECG monitors, among others).

This is Our Lane - Too: Joint Statement on the Maternal Health Crisis from the Association of Black Cardiologists, American College of Cardiology and American Heart Association

Retrieved on: 
Wednesday, May 17, 2023
ACC, Pregnancy, Obesity, Eclampsia, Diabetes, Education, American Heart Association, Gestational diabetes, Cardiovascular disease, Woman, Statistics, CVD, Cardiology, Black, AHA, Mother, Hypertension, Patient, Place of birth, Gestational hypertension, Risk, ABC, Pre-eclampsia, Disease, Racism, Mortality, Association of Black Cardiologists, Health, Bias, Death, White, Family, Nursing, Dietary supplement

Urgent action is needed to combat the maternal morbidity and mortality crisis in America and cardiologists have a vital role to play.

Key Points: 
  • Urgent action is needed to combat the maternal morbidity and mortality crisis in America and cardiologists have a vital role to play.
  • Urgent action is needed to combat the maternal health crisis in America and cardiologists have a vital role to play.
  • The ABC also launched the " We Are the Faces of Black Maternal Health™ " campaign in 2021 to tell the stories of the maternal health crisis faced by cardiologists along with their patients.
  • We encourage all cardiovascular specialists to double down on their efforts to reduce maternal mortality and to eliminate racial and ethnic gaps in maternal health outcomes.

Study Finds Arts, Nature and Tourism Less Appealing to People Who are Color Blind

Retrieved on: 
Tuesday, May 16, 2023
Theme Parks, Other Health, Tourist Attractions, University, Primary, Secondary, Education, Optical, Destinations, Travel, Other Entertainment, People with Disabilities, Arts, Museums, Entertainment, Consumer, Health, Learning, Centre Pompidou, Tourism, Friends, Chau Chak Wing Museum, Parent, Garden, Van Gogh Museum, University of California, Davis, AAM, Woman, Multimedia, CVD, Paratriathlon, School, Dallas Museum of Art, Student, Nature, Frustration, Timken Museum of Art, Sport, Family, Library, Common, Interior design, EnChroma, Museum, Art

View the full release here: https://www.businesswire.com/news/home/20230516005418/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230516005418/en/
    Announced at the American Alliance of Museums (AAM) Annual Meeting & MuseumExpo (Booth #829) taking place in Denver, the study asked color blind people how Color Vision Deficiency (CVD) impacts their enjoyment of various activities that involve color.
  • Nearly 60 percent (57%) said color blindness affects their desire to create art.
  • While people with normal color vision see over one million shades of color, the red-green color blind only see an estimated 10% of hues and shades.
  • EnChroma glasses are engineered with special optical filters that help the color blind see an expanded range of colors more vibrantly, clearly and distinctly.

AMC Health and the University of Mississippi Medical Center Partner to Improve Chronic Condition Care Through Remote Monitoring

Retrieved on: 
Tuesday, May 16, 2023
Software, Telemedicine, Virtual Medicine, Data Analytics, Managed Care, General Health, Health, Professional Services, Technology, Medical device, UMMC, Partnership, University, Prevalence, Diabetes, Health education, Stroke, Cardiovascular disease, Health equity, CVD, Risk, AMC, Hypertension, Death, Pharmacist, Vital signs, Patient, Machine learning, Mississippi Department of Corrections, RN, Conditional sentence, Mortality, RPM, University of Mississippi Medical Center, FDA, Health literacy, Self-management, Nursing, Pharmaceutical industry

The University of Mississippi Medical Center (UMMC) is partnering with AMC Health — a leading provider of remote patient monitoring (RPM) services — to broaden and enhance care for patients with chronic health conditions.

Key Points: 
  • The University of Mississippi Medical Center (UMMC) is partnering with AMC Health — a leading provider of remote patient monitoring (RPM) services — to broaden and enhance care for patients with chronic health conditions.
  • AMC Health, meanwhile, has been providing virtual care and RPM solutions for over two decades.
  • "We are thrilled to partner with the University of Mississippi Medical Center to improve the lives of patients with chronic diseases," said Nesim Bildirici, CEO of AMC Health.
  • AMC Health's innovative enterprise-wide RPM system combines remote monitoring technology, health education to improve health literacy and promote self-management, and evidence-based management protocols.

CVD Equipment Corporation Reports First Quarter 2023 Financial Results

Retrieved on: 
Monday, May 15, 2023
Other Manufacturing, Other Defense, Engineering, Chemicals, Plastics, Automotive Manufacturing, Aerospace, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Defense, EV, Electronics, Eastern Time Zone, Overalls, CMC, CVD, CVV, Carbon, CVI, Growth, Silicon, Crown Equipment Corporation, Cryptocurrency, Video game

CVD Equipment Corporation (NASDAQ: CVV ), today announced its financial results for the first quarter ended March 31, 2023.

Key Points: 
  • CVD Equipment Corporation (NASDAQ: CVV ), today announced its financial results for the first quarter ended March 31, 2023.
  • This resulted in a decrease in our backlog from $17.8 million at December 31, 2022 to $12.0 million at March 31, 2023.
  • We recognized $2.5 million of revenue during the first quarter of 2023 related to these orders and expect to ship the remaining 10 of 30 units during the second quarter.
  • Accordingly, we believe our orders received from customers and our revenue recognized will continue to fluctuate from quarter to quarter.

Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics

Retrieved on: 
Wednesday, May 10, 2023
Managed Care, Research, Other Health, Technology, Hospitals, Artificial Intelligence, Health Insurance, Clinical Trials, Science, Cardiology, Biotechnology, Practice Management, Health, Workforce, Private sector, Partnership, Employee Benefit Research Institute, Doctor of Philosophy, American Heart Association, Workplace, Cardiovascular disease, CVD, CDC, Journal of the American Heart Association, Korea Disease Control and Prevention Agency, Disease, Mortality, Pharmaceutical industry, Medical device, Health insurance

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced a partnership with Connect Clinic to help MidWest/South Central self-insured employers build access to heart disease initiatives.

Key Points: 
  • Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced a partnership with Connect Clinic to help MidWest/South Central self-insured employers build access to heart disease initiatives.
  • The innovative collaboration between Connect Clinic and Cardio Diagnostics aims to address this pressing issue by bringing state-of-the-art preventive heart disease testing directly to the workplace.
  • "The alliance between Connect Clinic and Cardio Diagnostics is a great step forward in the healthcare sector, particularly for self-insured employers in Oklahoma.
  • By aligning their distinct health services, Connect Clinic and Cardio Diagnostics aim to foster a healthier workforce and create a more sustainable healthcare ecosystem.